<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Opin Lipidol</journal-id><journal-id journal-id-type="iso-abbrev">Curr Opin Lipidol</journal-id><journal-id journal-id-type="pmc-domain-id">2035</journal-id><journal-id journal-id-type="pmc-domain">lwwopen</journal-id><journal-id journal-id-type="publisher-id">COLIP</journal-id><journal-title-group><journal-title>Current Opinion in Lipidology</journal-title></journal-title-group><issn pub-type="ppub">0957-9672</issn><issn pub-type="epub">1473-6535</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Lippincott Open Access</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10069755</article-id><article-id pub-id-type="pmcid-ver">PMC10069755.1</article-id><article-id pub-id-type="pmcaid">10069755</article-id><article-id pub-id-type="pmcaiid">10069755</article-id><article-id pub-id-type="pmid">36752614</article-id><article-id pub-id-type="doi">10.1097/MOL.0000000000000866</article-id><article-id pub-id-type="publisher-id">MOL340205</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>GENETICS &amp; MOLECULAR BIOLOGY: Edited by Robert Hegele</subject></subj-group></article-categories><title-group><article-title>Genetic determinants of pancreatitis: relevance in severe hypertriglyceridemia</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Hang</surname><given-names initials="SMT">Shyann M.T.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hegele</surname><given-names initials="RA">Robert A.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Berberich</surname><given-names initials="AJ">Amanda J.</given-names></name></contrib></contrib-group><aff>Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada</aff><author-notes><corresp>Correspondence to Amanda J. Berberich, MD, PhD, FRCPC, Assistant Professor of Medicine, Western University, Division of Endocrinology &amp; Metabolism, St. Joseph's Hospital, 268 Grosvenor Street, London, Ontario N6A 4V2, Canada. Tel: +1 519 646 6245; fax: +1 519 646 6067; e-mail: <email>Amanda.Berberich@sjhc.london.on.ca</email></corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>01</day><month>2</month><year>2023</year></pub-date><volume>34</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">432627</issue-id><fpage>59</fpage><lpage>69</lpage><pub-history><event event-type="pmc-release"><date><day>03</day><month>04</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>04</day><month>04</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-01-26 22:25:28.613"><day>26</day><month>01</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0</ext-link></license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="colip-34-59.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="colip-34-59.pdf"/><abstract><title>Purpose of review</title><p>Not all patients with severe hypertriglyceridemia develop acute pancreatitis. We surveyed recent literature on inter-individual genetic variation in susceptibility to pancreatitis.</p><sec><title>Recent findings</title><p>Genetic determinants of pancreatitis include: rare Mendelian disorders caused by highly penetrant pathogenic variants in genes involved in trypsinogen activation; uncommon susceptibility variants in genes involved in trypsinogen activation, protein misfolding as well as calcium metabolism and cystic fibrosis, that have variable penetrance and show a range of odds ratios for pancreatitis; and common polymorphisms in many of the same genes that have only a small effect on risk. The role of these genetic variants in modulating pancreatitis risk in hypertriglyceridemia is unclear. However, among genetic determinants of plasma triglycerides, those predisposing to more severe hypertriglyceridemia associated with chylomicronemia appear to have higher pancreatitis risk.</p></sec><sec sec-type="summary"><title>Summary</title><p>Currently, among patients with severe hypertriglyceridemia, the most consistent predictor of pancreatitis risk is the triglyceride level. Furthermore, pancreatitis risk appears to be modulated by a higher genetic burden of factors associated with greater magnitude of triglyceride elevation. The role of common and rare genetic determinants of pancreatitis itself in this metabolic context is unclear.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>chylomicronemia</kwd><kwd>chymotrypsin C</kwd><kwd>hereditary pancreatitis</kwd><kwd>human genetics</kwd><kwd>hypertriglyceridemia</kwd><kwd>lipoprotein lipase</kwd><kwd>monogenic disorder</kwd><kwd>polygenic trait</kwd><kwd>trypsinogen</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Severe hypertriglyceridemia is a complex, multifactorial condition that results from interactions between genetic predisposition and numerous secondary factors [<xref rid="R1" ref-type="bibr">1</xref>]. The risk to health of severe hypertriglyceridemia is acute pancreatitis and atherosclerotic cardiovascular disease (ASCVD) in many but not all cases [<xref rid="R1" ref-type="bibr">1</xref>]. Experienced clinicians have encountered patients with profound hypertriglyceridemia from chylomicronemia who avoid developing pancreatitis. Other patients develop pancreatitis at a relatively low threshold triglyceride level. The basis for inter-individual differences in expression of pancreatitis among patients with severe hypertriglyceridemia is unknown. Here we briefly review evidence that both rare and common genetic variants can explain inter-individual differences in susceptibility to pancreatitis generally and specifically in the context of hypertriglyceridemia.&#160;</p><fig position="float" id="FB1" orientation="portrait"><label>Box 1</label><caption><p>no caption available</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="colip-34-59-g001.jpg"/></fig></sec><sec sec-type="intro"><title>BRIEF OVERVIEW OF THE CLINICAL ISSUE</title><p>Acute pancreatitis is hallmarked by inflammation of the pancreas, resulting in severe epigastric pain, along with elevated serum pancreatic enzymes &#8211; particularly pancreatic lipase &#8211; sometimes together with radiographic findings [<xref rid="R2" ref-type="bibr">2<sup>&#9642;</sup></xref>]. Acute pancreatitis has an annual incidence of 10 to 35 per 100 000 individuals in North America, and compared to other acute conditions it is associated with relatively longer duration of hospitalization and higher mortality [<xref rid="R3" ref-type="bibr">3</xref>]. Acute pancreatitis episodes may recur leading to long term complications such as chronic pancreatitis, pancreatic pseudocyst formation, pancreatic necrosis, and pancreatic failure with endocrine and exocrine insufficiency [<xref rid="R2" ref-type="bibr">2<sup>&#9642;</sup></xref>].</p><p>The pathophysiology of acute pancreatitis has been attributed to diverse mechanisms including pathological calcium signaling, mitochondrial dysfunction, endoplasmic reticulum stress, an impaired unfolded protein response and impaired autophagy [<xref rid="R2" ref-type="bibr">2<sup>&#9642;</sup></xref>]. However, the most well accepted core mechanism is autodigestion due to premature trypsinogen activation into trypsin, which is the main enzyme responsible for the activation of digestive enzymes following its secretion into the duodenum. Premature activation of digestive enzymes by trypsin within the pancreas is thought to trigger injury. The ensuing local pro-inflammatory response in turn perpetuates pancreatic tissue damage. In more severe cases, local inflammation can activate a systemic inflammatory response syndrome, which may progress to multiorgan dysfunction and occasionally shock and death [<xref rid="R2" ref-type="bibr">2<sup>&#9642;</sup></xref>].</p><p>Common etiologies of acute pancreatitis include biliary disease (mainly gallstones), heavy alcohol consumption, hypertriglyceridemia or as a complication of endoscopic retrograde cholangio-pancreatography [<xref rid="R2" ref-type="bibr">2<sup>&#9642;</sup></xref>]. Less commonly pancreatitis can result from trauma, infections, drugs, toxins, or it can be idiopathic [<xref rid="R2" ref-type="bibr">2<sup>&#9642;</sup></xref>]. In addition, genetic factors can influence the risk of pancreatitis [<xref rid="R4" ref-type="bibr">4</xref><sup>&#9642;&#9642;</sup>,<xref rid="R5" ref-type="bibr">5<sup>&#9642;</sup></xref>,<xref rid="R6" ref-type="bibr">6<sup>&#9642;</sup></xref>,<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>,<xref rid="R8" ref-type="bibr">8<sup>&#9642;</sup></xref>,<xref rid="R9" ref-type="bibr">9<sup>&#9642;</sup></xref>], including pathogenic rare variants that cause hereditary forms of pancreatitis, and both rare and common genetic noncausal variants that predispose to pancreatitis either directly or as drivers of its risk factors (see Table <xref rid="T1" ref-type="table">1</xref>). Other factors that may influence expression of pancreatitis include gene&#8211;gene interactions, epigenetic or environmental influences, and individual patient attributes [<xref rid="R2" ref-type="bibr">2<sup>&#9642;</sup></xref>,<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>].</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Selected genetic determinants of pancreatitis</p></caption><table frame="hsides" rules="groups" border="0"><thead><tr><td align="left" rowspan="1" colspan="1">Gene symbol</td><td align="left" rowspan="1" colspan="1">OMIM identifier</td><td align="left" rowspan="1" colspan="1">Cytogenetic location</td><td align="left" rowspan="1" colspan="1">Gene product</td><td align="left" rowspan="1" colspan="1">Causal high penetrance rare variants</td><td align="left" rowspan="1" colspan="1">Predisposing moderate to small effect rare variants</td><td align="left" rowspan="1" colspan="1">Predisposing small effect common variants</td><td align="left" rowspan="1" colspan="1">Comments</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">PRSS1</italic>
</td><td align="left" rowspan="1" colspan="1">276000</td><td align="left" rowspan="1" colspan="1">7q34</td><td align="left" rowspan="1" colspan="1">Cationic trypsinogen</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">Variants can act through either trypsin-dependent pathway or misfolding-dependent pathway</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">SPINK1</italic>
</td><td align="left" rowspan="1" colspan="1">167790</td><td align="left" rowspan="1" colspan="1">5q32</td><td align="left" rowspan="1" colspan="1">Pancreatic secretory trypsin inhibitor Kazal type 1</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">Variants can act through either trypsin-dependent pathway or misfolding-dependent pathway</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">PRSS2</italic>
</td><td align="left" rowspan="1" colspan="1">601564</td><td align="left" rowspan="1" colspan="1">7q34</td><td align="left" rowspan="1" colspan="1">Anionic trypsinogen</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">Trypsin-dependent pathway</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">CTRC</italic>
</td><td align="left" rowspan="1" colspan="1">601405</td><td align="left" rowspan="1" colspan="1">1p36</td><td align="left" rowspan="1" colspan="1">Chymotrypsin C</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">Trypsin-dependent pathway</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">CPA1</italic>
</td><td align="left" rowspan="1" colspan="1">114850</td><td align="left" rowspan="1" colspan="1">7q32</td><td align="left" rowspan="1" colspan="1">Carboxypeptidase A1</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">X</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Misfolding-dependent pathway</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">CEL</italic>
</td><td align="left" rowspan="1" colspan="1">114840</td><td align="left" rowspan="1" colspan="1">9q34</td><td align="left" rowspan="1" colspan="1">Carboxyl ester lipase</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">X</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Misfolding-dependent pathway</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">CFTR</italic>
</td><td align="left" rowspan="1" colspan="1">602421</td><td align="left" rowspan="1" colspan="1">7q31</td><td align="left" rowspan="1" colspan="1">Cystic fibrosis transmembrane regulator</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">X</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Certain heterozygous variants predispose to pancreatitis by affecting pancreatic duct physiology</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">CLDN2</italic>
</td><td align="left" rowspan="1" colspan="1">300520</td><td align="left" rowspan="1" colspan="1">Xq22</td><td align="left" rowspan="1" colspan="1">Claudin 2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">GWAS locus; linked to <italic toggle="yes">MORC4</italic> gene encoding zinc finger CW domain protein 4</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">CTRB1/CTRB2</italic>
</td><td align="left" rowspan="1" colspan="1">118890/ 619620</td><td align="left" rowspan="1" colspan="1">16q23</td><td align="left" rowspan="1" colspan="1">Chymotrypsin B1 and B2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">GWAS locus; gene inversion variant</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">CASR</italic>
</td><td align="left" rowspan="1" colspan="1">601199</td><td align="left" rowspan="1" colspan="1">3q13</td><td align="left" rowspan="1" colspan="1">Calcium sensing receptor</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">X</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Variants predispose by altering calcium metabolism</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">TRPV6</italic>
</td><td align="left" rowspan="1" colspan="1">606680</td><td align="left" rowspan="1" colspan="1">7q34</td><td align="left" rowspan="1" colspan="1">Transporter receptor potential cation channel subfamily V member 6</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">X</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Variants predispose by altering calcium metabolism</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>GWAS, genome-wide association study; OMIM, Online Mendelian Inheritance in Man.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>CAUSAL GENETIC VARIANTS FOR HEREDITARY PANCREATITIS</title><p>Acute, recurrent acute and chronic pancreatitis essentially form a phenotypic continuum with overlapping pathogenic mechanisms [<xref rid="R2" ref-type="bibr">2<sup>&#9642;</sup></xref>]. Their genetic determinants also overlap somewhat [<xref rid="R4" ref-type="bibr">4</xref><sup>&#9642;&#9642;</sup>,<xref rid="R5" ref-type="bibr">5<sup>&#9642;</sup></xref>,<xref rid="R6" ref-type="bibr">6<sup>&#9642;</sup></xref>]. The term &#8220;hereditary pancreatitis&#8221; refers to a small subset of cases that clearly show a monogenic, Mendelian pattern of inheritance in multigenerational families. Most gene variants associated with hereditary pancreatitis lead to altered activation and degradation of trypsinogen into trypsin, including gain-of-function variants and proteotoxic variants [<xref rid="R2" ref-type="bibr">2<sup>&#9642;</sup></xref>,<xref rid="R4" ref-type="bibr">4</xref><sup>&#9642;&#9642;</sup>,<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>]. Also, cellular mechanisms are normally in place to guard against premature trypsin activation within the pancreas [<xref rid="R6" ref-type="bibr">6<sup>&#9642;</sup></xref>]. Pathogenic variants in the genes that encode protective factors, for example, <italic toggle="yes">SPINK1</italic>, can predispose to pancreatitis and underlie many cases of hereditary pancreatitis [<xref rid="R4" ref-type="bibr">4</xref><sup>&#9642;&#9642;</sup>,<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>]. Because these rare Mendelian disorders are expressed early in life and affected individuals have relapsing acute pancreatitis, the phenotype can evolve into chronic pancreatitis, which is the commonest reported hereditary phenotype [<xref rid="R6" ref-type="bibr">6<sup>&#9642;</sup></xref>]. Genetic loci are often similar for acute and chronic pancreatitis. These loci were usually discovered by genetic mapping efforts in affected families or in case-control experiments.</p><p>Using the most stringent criteria for causality from the American College of Medical Genetics and Genomics [<xref rid="R10" ref-type="bibr">10</xref>] &#8211; that is, very rare allele frequency together with phenotype&#8211;genotype co-segregation in multigenerational families plus molecular dysfunction demonstrated either experimentally or through essentially unequivocal bioinformatic modeling &#8211; only two genes can be said to have naturally occurring human pathogenic variants that cause hereditary pancreatitis [<xref rid="R11" ref-type="bibr">11</xref>]. These are heterozygous gain-of-function variants in <italic toggle="yes">PRSS1</italic> (OMIM 276000) encoding cationic trypsinogen and heterozygous loss-of-function variants in <italic toggle="yes">SPINK1</italic> (OMIM 167790) encoding pancreatic secretory trypsin inhibitor Kazal type 1. These gene products are categorized mechanistically under the &#8220;trypsin-dependent pathway&#8221; (Table <xref rid="T1" ref-type="table">1</xref>).</p></sec><sec><title>HEREDITARY PANCREATITIS DUE TO CAUSAL VARIANTS IN THE <italic toggle="yes">PRSS1</italic> GENE</title><p>Gain-of-function variants in <italic toggle="yes">PRSS1</italic> include copy number and missense variants and also gain-of-proteotoxicity missense variants that result in increased trypsinogen activation and/or increased trypsin stability, eventually promoting trypsin-mediated autodigestion within pancreatic acinar cells. Pathogenic gain-of-function variants in <italic toggle="yes">PRSS1</italic> have been implicated in &#8764;80% of cases of autosomal dominant hereditary pancreatitis [<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>]. However, fewer than two dozen families with pathogenic <italic toggle="yes">PRSS1</italic> variants have been reported. The most recurring variant is <italic toggle="yes">PRSS1</italic> p.Arg122His, which has 93% penetrance for pancreatitis and shows typical autosomal dominant inheritance. Penetrance of pancreatitis in carriers of some other <italic toggle="yes">PRSS1</italic> variants is variable and is influenced by secondary factors.</p><p>The functional consequence of pathogenic gain-of-function variants in <italic toggle="yes">PRSS1</italic> is to either prevent chymotrypsin C (CTRC)-mediated trypsinogen degradation, increase trypsinogen autoactivation, or cause trypsinogen misfolding that results in reduced secretion, intracellular retention and elevated endoplasmic reticulum stress markers [<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>]. <italic toggle="yes">PRSS1</italic> variants in children predict aggressive disease with earlier onset and rapid progression to chronic pancreatitis, with a more severe disease phenotype associated with p.Arg122His and p.Asn29Ile variants [<xref rid="R12" ref-type="bibr">12</xref>]. But because highly penetrant pathogenic <italic toggle="yes">PRSS1</italic> gain-of-function variants are rare, they are not major contributors to inter-individual variation in pancreatitis susceptibility either in the general population or in those with severe hypertriglyceridemia.</p></sec><sec><title>HEREDITARY PANCREATITIS DUE TO CAUSAL VARIANTS IN THE <italic toggle="yes">SPINK1</italic> GENE</title><p>The gene product of <italic toggle="yes">SPINK1</italic> is expressed in pancreatic acinar cells during an inflammatory reaction and acts to inhibit prematurely activated intrapancreatic trypsin [<xref rid="R13" ref-type="bibr">13</xref>]. Loss-of-function variants in <italic toggle="yes">SPINK1</italic> can undermine this protective effect, resulting in increased trypsin-mediated digestion within acinar cells. However, in the absence of the background of pancreatic inflammation, pathogenic variants in <italic toggle="yes">SPINK1</italic> appear to have minimal impact on pancreatitis risk. The most frequently reported rare pathogenic variants are <italic toggle="yes">SPINK</italic> p.Asn34Ser in Europeans and c.194+2T&gt;C in Korean and Han Chinese patients, respectively [<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref>]. Interestingly, the <italic toggle="yes">SPINK</italic> p.Asn34Ser variant was recently shown to be a surrogate marker linked genetically with a dysfunctional noncoding regulatory variant &#8764;4&#8202;kb upstream of the <italic toggle="yes">SPINK1</italic> gene [<xref rid="R16" ref-type="bibr">16</xref>]. Inheritance patterns have been described as both autosomal recessive in families with a history of familial pancreatitis carrying two mutations and autosomal dominant in individuals with chronic pancreatitis and a single-copy heterozygous <italic toggle="yes">SPINK1</italic> mutation. Given these various caveats, rare <italic toggle="yes">SPINK1</italic> loss-of-function variants are unlikely to be major contributors to pancreatitis susceptibility either in the general population or in those with severe hypertriglyceridemia.</p></sec><sec><title>RARE GENETIC VARIANTS THAT PREDISPOSE TO PANCREATITIS</title><p>Masson <italic toggle="yes">et al.</italic>[<xref rid="R11" ref-type="bibr">11</xref>] recently suggested using the term &#8220;familial pancreatitis&#8221; for clinical presentations in which association with either rare or common genetic variants is shown statistically in unrelated people, but for which there is minimal evidence of transgenerational inheritance. This more liberal phenotypic definition compared to &#8220;hereditary pancreatitis&#8221; expands the range of genetic loci and variant types that are determinants of pancreatitis. Since such variants are cumulatively more prevalent, they also include a larger segment of the population. Although variants of this type are not definitively or absolutely associated with disease expression, they are statistically associated, which might nonetheless be useful for predicting pancreatitis risk. Finally, such genetic variants might explain some inter-individual differences in hypertriglyceridemia-associated pancreatitis risk.</p></sec><sec><title>TRYPSIN-DEPENDENT PATHWAY SUSCEPTIBILITY VARIANTS IN THE <italic toggle="yes">PRSS1</italic>, <italic toggle="yes">PRSS2</italic> AND <italic toggle="yes">SPINK1</italic> GENES</title><p>The ultrarare pathogenic <italic toggle="yes">PRSS1</italic> and <italic toggle="yes">SPINK1</italic> Mendelian variants described above fit within the &#8220;trypsin-dependent pathway&#8221; mechanistic subgroup [<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>,<xref rid="R11" ref-type="bibr">11</xref>]. But, this subgroup also includes many more rare variants in these two genes that predispose to rather than directly cause pancreatitis. Most of the &gt;50 pancreatitis-associated variants in <italic toggle="yes">PRSS1</italic> show modest or weak effects - consistent with lower penetrance - compared with the strong effect pathogenic variants in hereditary pancreatitis families. For instance, the well known infrequent <italic toggle="yes">PRSS1</italic> p.Arg122His and p.Gly208Ala variants have odds ratios for pancreatitis ranging from 4 to 10 [<xref rid="R11" ref-type="bibr">11</xref>], consistent with predisposition but not causation.</p><p>Adjacent to <italic toggle="yes">PRSS1</italic> on chromosome 7q34 is <italic toggle="yes">PRSS2</italic> (OMIM 601564) encoding anionic trypsinogen. No highly penetrant causal variants have been reported in this gene, although the <italic toggle="yes">PRSS2</italic> p.Gly191Arg variant has a 5% population frequency and reduces pancreatitis risk by &#8764;3&#8722;6-fold, possibly because the variant protein is prone to autocatalysis and inactivation [<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>]. The overall absence of pathogenic <italic toggle="yes">PRSS2</italic> Mendelian variants is notable, although reasons for this are unclear [<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>].</p><p>On the other hand, &gt;30 rare disease-associated variants have been reported in <italic toggle="yes">SPINK1</italic>, most of which are incompletely penetrant and show a wide range of odds ratios for pancreatitis [<xref rid="R13" ref-type="bibr">13</xref>]. As with most <italic toggle="yes">PRSS1</italic> variants, most <italic toggle="yes">SPINK1</italic> variants alone are not sufficient for developing pancreatitis, since their prevalence is &#8764;1&#8722;2% in the general healthy population [<xref rid="R12" ref-type="bibr">12</xref>]. Here, the development of pancreatitis likely requires additional environmental, patient or genetic factors. But while they do not deliver a 100% chance of developing pancreatitis, the odds ratios are relatively large compared to variants in other complex diseases. Future research will determine whether measuring these predisposing effects is clinically useful.</p></sec><sec><title>TRYPSIN-DEPENDENT PATHWAY PREDISPOSING VARIANTS IN THE <italic toggle="yes">CTRC</italic> GENE</title><p>Another gene whose product acts within the trypsin-dependent pathway and which harbors predisposing rare variants for pancreatitis is <italic toggle="yes">CTRC</italic> (OMIM 601405) encoding chymotrypsin C. CTRC specifically degrades trypsinogen/trypsin, and loss-of-function variants enhance autodigestion [<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>]. No families with co-segregation of <italic toggle="yes">CTRC</italic> variants and pancreatitis phenotypes have been reported. However, statistical associations of these variants with pancreatitis in the unrelated general population have been replicated. For instance, the <italic toggle="yes">CTRC</italic> p.Arg254Trp variant has an odds ratio for pancreatitis of &#8764;2&#8722;3, whereas a bundle of rare <italic toggle="yes">CTRC</italic> loss-of-function variants has an odds ratio for pancreatitis of &#8764;4 [<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>]. Compared with genetic factors in other complex diseases, the odds ratios for such <italic toggle="yes">CTRC</italic> variants in pancreatitis are relatively large. This might be useful clinically, especially if combined with other genetic markers to increase discriminatory and predictive power.</p></sec><sec><title>MISFOLDING-DEPENDENT PATHWAY OF GENETIC RISK OF PANCREATITIS</title><p>Other trypsin-dependent genes have rare predisposing variants that act through a distinct pathogenic mechanism referred to as the &#8220;misfolding-dependent pathway&#8221; [<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>]. This pathogenic mechanism is characterized by decreased secretion of the misfolded mutant protein, resulting in intracellular accumulation and increased endoplasmic reticulum stress leading ultimately to acinar cell damage. As mentioned above, a few pathogenic variants in <italic toggle="yes">PRSS1</italic> in hereditary pancreatitis families are referred to as proteotoxic because of misfolding. Other proteotoxic <italic toggle="yes">PRSS1</italic> misfolding variants that have been found in sporadic cases of pancreatitis include p.Cys139Phe, p.Cys139Ser and p.Leu104Phe [<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>].</p><p>Another gene locus with pancreatitis predisposing variants that act via a protein misfolding trypsin-independent mechanism is <italic toggle="yes">CPA1</italic> (OMIM 114850) encoding carboxypeptidase A1 [<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>]. Certain rare <italic toggle="yes">CPA1</italic> variants cause misfolding with intracellular accumulation of protein and increased endoplasmic reticulum stress and were associated with odds ratios of &gt;25 for chronic and early onset sporadic pancreatitis [<xref rid="R17" ref-type="bibr">17</xref>]. A few <italic toggle="yes">CPA1</italic> variants appeared to show familial inheritance [<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr">19</xref>]. However, enthusiasm for this gene has been curbed by observations suggesting that most apparently pathogenic <italic toggle="yes">CPA1</italic> variants are not associated with pancreatitis [<xref rid="R20" ref-type="bibr">20</xref>]. More work is required to establish the importance of <italic toggle="yes">CPA1</italic> in predisposition to pancreatitis.</p><p>Similar unreplicated associations exist between for pathogenic variants in <italic toggle="yes">CEL</italic> (OMIM 114840) encoding carboxyl ester lipase, which interestingly is also the causal gene for maturity-onset diabetes of the young type 8 (MODY8) [<xref rid="R7" ref-type="bibr">7</xref><sup>&#9642;&#9642;</sup>]. One particular pancreatitis-associated large-scale variant called <italic toggle="yes">CEL-HYB1</italic> is an abnormal hybrid allele resulting from a recombination event between <italic toggle="yes">CEL</italic> and its neighboring pseudogene <italic toggle="yes">CELP</italic>; its population frequency is 1&#8211;2% [<xref rid="R21" ref-type="bibr">21</xref>]. The abnormal gene product is prone to misfolding [<xref rid="R22" ref-type="bibr">22</xref>] and the risk of chronic pancreatitis associated with <italic toggle="yes">CEL-HYB1</italic> was increased by five-fold [<xref rid="R21" ref-type="bibr">21</xref>]. In contrast, a second <italic toggle="yes">CEL-HYB</italic> allele with a premature stop codon in exon 10 described in a study of three Asian populations was found to not be associated with chronic pancreatitis [<xref rid="R23" ref-type="bibr">23</xref>]. As with most susceptibility loci, more work is required to definitively establish the role of <italic toggle="yes">CEL</italic> in pancreatitis risk.</p></sec><sec><title>PREDISPOSING VARIANTS FOR PANCREATITIS IN THE <italic toggle="yes">CFTR</italic> GENE</title><p>Pathogenic variants in <italic toggle="yes">CFTR</italic> (OMIM 602421) encoding the cystic fibrosis transmembrane conductance regulator, with or without concurrent manifestations of classical cystic fibrosis, can confer increased risk for pancreatitis and pancreatic damage as a result of failure to clear pancreatic ducts from elevated mucus levels, with progression to fibrosis and cysts [<xref rid="R24" ref-type="bibr">24</xref>]. Cystic fibrosis is an autosomal recessive disorder that results from the presence of two severe <italic toggle="yes">CFTR</italic> loss-of-function variants [<xref rid="R24" ref-type="bibr">24</xref>]. Some severe <italic toggle="yes">CFTR</italic> mutations can lead to early-onset pancreatic insufficiency, often in infancy or childhood [<xref rid="R24" ref-type="bibr">24</xref>]. Patients with both a severe and mild <italic toggle="yes">CFTR</italic> pathogenic variant are more likely to present with episodes of acute pancreatitis [<xref rid="R25" ref-type="bibr">25</xref>]. Heterozygous carriers of either <italic toggle="yes">CFTR</italic> p.Phe508del or p.Arg117His have also been found to be enriched among chronic pancreatitis patients, with reported odds ratios of &#8764;2&#8211;3 [<xref rid="R8" ref-type="bibr">8<sup>&#9642;</sup></xref>]. Because they are relatively common across geographic ancestries, screening for heterozygous <italic toggle="yes">CFTR</italic> variants in hypertriglyceridemia-associated pancreatitis may be worthwhile.</p></sec><sec><title>COMMON VARIANTS FOR PANCREATITIS FROM GENOME-WIDE ASSOCIATION STUDIES</title><p>Genome-wide association studies (GWAS) utilizing common, mostly nonfunctional single nucleotide polymorphisms (SNPs) positioned strategically and densely across the genome are a standard tool for finding genetic determinants of complex traits [<xref rid="R26" ref-type="bibr">26</xref>]. One benefit of GWAS is identification of multiple disease-associated SNP genotypes that can be combined into a polygenic score, which is a proven metric to test scientific and clinical hypotheses [<xref rid="R26" ref-type="bibr">26</xref>]. Interestingly, typical case&#8211;control GWAS for pancreatitis are relatively scarce and no polygenic score appears to have yet been reported for pancreatitis, despite numerous publications of polygenic scores for other pancreatic disorders, such as pancreatic cancer. Nonetheless, significant GWAS findings for pancreatitis are worth discussing in detail.</p><p>In 2018, Rosendahl <italic toggle="yes">et al.</italic>[<xref rid="R27" ref-type="bibr">27</xref>] reported a GWAS in 1959 and 1659 mainly European patients with alcoholic and nonalcoholic chronic pancreatitis, respectively, and &gt;11 000 total control subjects. They identified and replicated several highly significant pancreatitis-associated SNP loci, including signals at the well known loci <italic toggle="yes">CTRC</italic>, <italic toggle="yes">PRSS1</italic>, <italic toggle="yes">PRSS2</italic> and <italic toggle="yes">SPINK1</italic>[<xref rid="R27" ref-type="bibr">27</xref>]. Furthermore, they found two additional significant pancreatitis-associated GWAS signals, that is, SNPs at the <italic toggle="yes">CLDN2-MORC4</italic> gene locus and a common complex genetic variant designated as the <italic toggle="yes">CTRB1-CTRB2</italic> inversion [<xref rid="R27" ref-type="bibr">27</xref>].</p><p>In 2022, Schmidt <italic toggle="yes">et al.</italic>[<xref rid="R28" ref-type="bibr">28<sup>&#9642;</sup></xref>] reported a GWAS in 584 mainly European patients with nonalcoholic chronic pancreatitis and 6040 controls coupled with analysis of RNA transcripts in alcohol-exposed pancreatic tissue. They found that common variants at <italic toggle="yes">CTRC</italic> and <italic toggle="yes">SPINK1</italic> reached genome-wide significance in nonalcoholic chronic pancreatitis, while <italic toggle="yes">CTRC</italic> and <italic toggle="yes">CLDN2-MORC4</italic> risk variants colocalized with altered mRNA expression in pancreatic tissue [<xref rid="R28" ref-type="bibr">28<sup>&#9642;</sup></xref>]. The concordance of findings between the independent GWAS of Rosendahl <italic toggle="yes">et al.</italic>[<xref rid="R27" ref-type="bibr">27</xref>] and Schmidt <italic toggle="yes">et al.</italic>[<xref rid="R28" ref-type="bibr">28<sup>&#9642;</sup></xref>] was notable, since the top loci in both studies were identical to known loci described above, that is, <italic toggle="yes">CTRC</italic>, <italic toggle="yes">SPINK1</italic> and <italic toggle="yes">PRSS1</italic>. In addition, the novel strong signals for <italic toggle="yes">CLDN2-MORC4</italic> and the <italic toggle="yes">CTRB1-CTRB2</italic> inversion deserve further comment.</p><p><italic toggle="yes">CLDN2</italic> encodes claudin-2 (OMIM 300520) which is expressed in multiple tissues and is probably important in maintaining tight junctions between cells. Previously, rare <italic toggle="yes">CLDN2</italic> pathogenic variants were associated with chronic pancreatitis [<xref rid="R29" ref-type="bibr">29</xref>], and common SNPs at the <italic toggle="yes">CLDN2-MORC4</italic> locus, namely rs7057398 and rs12688220 were associated with chronic pancreatitis risk in subjects of East Asian and South Asian ancestry [<xref rid="R30" ref-type="bibr">30</xref>]. The replication in independent samples indicates that genetic variation at this locus should continue to be studied, especially in the context of polygenic risk of pancreatitis.</p><p>The 16.6&#8202;kb inversion of the <italic toggle="yes">CTRB1</italic> (OMIM 118890)<italic toggle="yes">/CTRB2</italic> (OMIM 619620) locus on chromosome 16q23, encoding chymotrypsin B1 and chymotrypsin B2, respectively, is the major &#8211; that is, more common &#8211; allele in both European and Chinese populations, with frequencies of &#8764;0.8 and &#8764;1.0, respectively [<xref rid="R31" ref-type="bibr">31</xref>]. The essentially monomorphic allele frequency indicates that it cannot be an important determinant of pancreatitis risk in Chinese people. Furthermore, DNA sequencing of the <italic toggle="yes">CTRB1&#8211;CTRB2</italic> locus did not reveal an association between rare variants with either alcoholic or nonalcoholic chronic pancreatitis [<xref rid="R32" ref-type="bibr">32</xref>]. Given these discrepancies, the potential scientific and clinical utility of variants at <italic toggle="yes">CTRB1/CTRB2</italic> in predisposition to pancreatitis is unclear.</p></sec><sec><title>MISCELLANEOUS GENETIC VARIANTS STUDIED FOR ASSOCIATION WITH PANCREATITIS</title><p>Numerous small case-control and cohort candidate gene association studies have reported pancreatitis-associated variants at gene loci such as <italic toggle="yes">FUT2</italic> (OMIM 182100) encoding fucosyltransferase 2 [<xref rid="R33" ref-type="bibr">33</xref>], <italic toggle="yes">UBR1</italic> (OMIM 605981) encoding ubiquitin ligase E3 alpha [<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R35" ref-type="bibr">35</xref>], <italic toggle="yes">GGT1</italic> (OMIM 612346) encoding gamma-glutamyltransferase [<xref rid="R36" ref-type="bibr">36</xref>], <italic toggle="yes">PNLIP</italic> (OMIM 246600) encoding pancreatic lipase [<xref rid="R37" ref-type="bibr">37</xref>] and <italic toggle="yes">CELA3B</italic> (OMIM 618694) encoding chymotrypsin-like elastase 3B [<xref rid="R38" ref-type="bibr">38</xref>]. Recently, for <italic toggle="yes">CELA3B</italic>, rare pathogenic variants have been reported in patients with pancreatitis, supporting the idea that this could be a valid candidate gene [<xref rid="R39" ref-type="bibr">39</xref>]. However, for the other genes, the findings have generally not been replicated in larger-scale GWAS nor supported by mechanistic data, and we feel they probably should not merit further consideration until such evidence is available.</p><p>Because of the role of proinflammatory cytokines in progression to severe pancreatitis, variants in selected candidate genes for these pathways have also been studied for association with pancreatitis. A comprehensive meta-analysis by Van den Berg <italic toggle="yes">et al.</italic>[<xref rid="R40" ref-type="bibr">40</xref><sup>&#9642;&#9642;</sup>] found that most studies were negative, with some borderline evidence in favor of associations with acute pancreatitis for variants at <italic toggle="yes">IL1B</italic> and <italic toggle="yes">IL6</italic> genes, encoding interleukins 1B and 6, respectively. However, neither locus has been prominent in GWAS of pancreatitis [<xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R28" ref-type="bibr">28<sup>&#9642;</sup></xref>]. Similarly, findings for common variants in candidate genes involved in oxidative stress and apoptosis, such as several encoding members of the glutathione S-transferase, caspase, tumor necrosis factor and tumor associated protein gene families were negative [<xref rid="R41" ref-type="bibr">41</xref>], and need not be considered further unless new data emerge.</p></sec><sec sec-type="results"><title>GENETIC DETERMINANTS OF PANCREATITIS RISK FACTORS: RESULTS FROM MENDELIAN RANDOMIZATION</title><p>Yuan <italic toggle="yes">et al.</italic>[<xref rid="R42" ref-type="bibr">42</xref><sup>&#9642;&#9642;</sup>] in 2021 reported a study of &gt;360 000 individuals from the UK BioBank and &gt;12 200 individuals from the FinnGen consortium. They constructed genetic instruments to serve as surrogate variables for lifelong exposure to known pancreatitis risk factors including gallstone disease, cigarette smoking, diabetes, serum calcium levels, serum triglycerides, and alcohol consumption. They constructed their genetic instruments for: gallstones using 32 previously reported GWAS SNPs from an Icelandic population [<xref rid="R43" ref-type="bibr">43</xref>]; smoking initiation using 378 SNPs from GWAS in &gt;1.2 million individuals [<xref rid="R44" ref-type="bibr">44</xref>]; diabetes using 558 SNPs from GWAS in &gt;1.4 million individuals [<xref rid="R45" ref-type="bibr">45</xref>]; serum calcium using 7 SNPs from GWAS in &gt;60 000 Europeans [<xref rid="R46" ref-type="bibr">46</xref>]; triglycerides using 440 previously reported SNPs from GWAS in &gt;400 000 Europeans [<xref rid="R47" ref-type="bibr">47</xref>]; and alcohol consumption using 99 SNPs from GWAS in &gt;900 000 Europeans [<xref rid="R44" ref-type="bibr">44</xref>]. For acute pancreatitis, significant odds ratios were 1.74, 1.15, 1.56 and 1.14 for gallstone disease, triglycerides, smoking and diabetes, respectively [<xref rid="R42" ref-type="bibr">42</xref><sup>&#9642;&#9642;</sup>]. For chronic pancreatitis, significant odds ratios were 1.27, 1.47 and 1.86 for gallstone disease, triglycerides and smoking, respectively [<xref rid="R42" ref-type="bibr">42</xref><sup>&#9642;&#9642;</sup>]. Because Mendelian randomization studies claim to identify causal relationships, the results from Yuan <italic toggle="yes">et al.</italic>[<xref rid="R42" ref-type="bibr">42</xref><sup>&#9642;&#9642;</sup>] support the idea that common genetic determinants for gallstone disease, diabetes, smoking and triglycerides are directly causal for pancreatitis itself. However, caveats in the design and interpretation of Mendelian randomization studies mean that results are not automatically infallible [<xref rid="R48" ref-type="bibr">48</xref>]. It would be important to replicate these findings using an analogous study design in other cohorts and populations.</p></sec><sec><title>GENETIC DETERMINANTS OF PANCREATITIS IN THE CONTEXT OF HYPERCALCEMIA</title><p>Hypercalcemia is a risk state for pancreatitis although it is less common than gallstones, alcohol use or even hypertriglyceridemia. Primary hyperparathyroidism with hypercalcemia has been found in &lt;0.5% of cases of pancreatitis [<xref rid="R49" ref-type="bibr">49</xref>], and about 90% of patients with hypercalcemia have either primary hyperparathyroidism or a malignancy [<xref rid="R50" ref-type="bibr">50</xref>]. General consideration of genetic etiologies for hypercalcemia is beyond the scope of this review; for instance, some cases of hyperparathyroidism are part of multiple endocrine neoplasia syndromes, which have a distinctive clinical presentation and genetic basis [<xref rid="R51" ref-type="bibr">51</xref>]. However, certain genes in calcium metabolism, including <italic toggle="yes">CASR</italic> (OMIM 601199) encoding the calcium sensing receptor and <italic toggle="yes">TRPV6</italic> (OMIM 606680) encoding transporter receptor potential cation channel subfamily V member 6 (also the gene for transient neonatal hyperparathyroidism) are predisposition loci for pancreatitis and will thus be discussed here briefly.</p><p>The <italic toggle="yes">CASR</italic> gene product is a G-protein-coupled receptor that is expressed in human pancreatic acinar and ductal cells as well as nonexocrine cells, and is the causal gene for hypocalciuric hypercalcemia, type I [<xref rid="R52" ref-type="bibr">52</xref>]. <italic toggle="yes">CASR</italic> variants were reported to play a role in <italic toggle="yes">SPINK1</italic>-related chronic pancreatitis [<xref rid="R52" ref-type="bibr">52</xref>] and an alcohol-dependent association between chronic pancreatitis and the <italic toggle="yes">CASR</italic> p.Arg990Gly variant was reported in a US population [<xref rid="R53" ref-type="bibr">53</xref>]. However, other studies have found no associations between common <italic toggle="yes">CASR</italic> gene variants and pancreatitis [<xref rid="R54" ref-type="bibr">54</xref>].</p><p>The <italic toggle="yes">TRPV6</italic> gene encodes a calcium selective ion channel that is predominantly expressed in pancreatic ducts. Functionally defective <italic toggle="yes">TRPV6</italic> variants were observed in a cohort of Japanese patients [<xref rid="R55" ref-type="bibr">55</xref>] and replicated in European patient cohorts [<xref rid="R56" ref-type="bibr">56</xref>,<xref rid="R57" ref-type="bibr">57</xref>]. <italic toggle="yes">TRPV6</italic> expression was decreased with these variants, supporting a mechanistic role of the cation channels in pancreatitis risk.</p></sec><sec><title>GENETIC PREDISPOSITION TO SEVERE HYPERTRIGLYCERIDEMIA AND PANCREATITIS RISK</title><p>Hypertriglyceridemia is seen in up to 10% of all acute pancreatitis episodes [<xref rid="R4" ref-type="bibr">4</xref><sup>&#9642;&#9642;</sup>]. Hypertriglyceridemia is both a risk factor and factor that modulates the severity of clinical presentation of pancreatitis [<xref rid="R58" ref-type="bibr">58</xref>]. Mislocalization of pancreatic lipase in the plasma compartment is considered to be important in pathogenesis, although several mechanisms have been proposed [<xref rid="R59" ref-type="bibr">59<sup>&#9642;</sup></xref>]. The threshold plasma triglyceride level that triggers an episode of acute pancreatitis is variable, but to a first approximation pancreatitis risk is proportional to triglyceride levels [<xref rid="R60" ref-type="bibr">60</xref>]. This gradient of risk is seen even at mild-to-moderate levels of triglycerides [<xref rid="R61" ref-type="bibr">61</xref>]. However, this could simply reflect the fact that mild-to-moderate hypertriglyceridemia is a risk marker for future onset of severe hypertriglyceridemia rather than being directly causal for pancreatitis.</p><p>Severe hypertriglyceridemia is sometimes defined as fasting triglycerides &gt;10&#8202;mmol/l (&gt;885&#8202;mg/dl) [<xref rid="R62" ref-type="bibr">62</xref>], a level seen in about 1 in 400 adults in North America [<xref rid="R63" ref-type="bibr">63</xref>]. Triglyceride levels this high indicate the pathological presence of fasting chylomicrons and are threshold for high risk of pancreatitis [<xref rid="R64" ref-type="bibr">64</xref>]. This risk increases sharply with triglycerides &gt; 20&#8202;mmol/l (&gt;1770&#8202;mg/dl) [<xref rid="R64" ref-type="bibr">64</xref>]; above this level the risk of pancreatitis is 4% over 1 year and 6% over 2 years [<xref rid="R63" ref-type="bibr">63</xref>].</p><p>Chylomicronemia syndrome implies one or more characteristic clinical features that include failure to thrive, nausea, vomiting, diarrhea, abdominal pain, lipemia retinalis, eruptive xanthomas, hepatosplenomegaly, anemia, gastrointestinal bleeding, diarrhea, seizures, and encephalopathy [<xref rid="R62" ref-type="bibr">62</xref>]. The two main chylomicronemia syndromes are familial chylomicronemia syndrome and multifactorial chylomicronemia syndrome [<xref rid="R62" ref-type="bibr">62</xref>]. Familial chylomicronemia syndrome is a Mendelian recessive condition caused by biallelic rare pathogenic loss-of-function variants in lipolysis-related genes, namely <italic toggle="yes">LPL</italic> (OMIM 609708) encoding lipoprotein lipase and accounts for 60&#8211;80% of cases, <italic toggle="yes">APOC2</italic> (OMIM 608083) encoding apolipoprotein (apo) C-II; <italic toggle="yes">APOA5</italic> (OMIM 606368) encoding apo A-V, <italic toggle="yes">GPIHBP1</italic> (OMIM 612757) encoding glycosylphosphatidylinositol HDL binding protein 1, and LMF1 (OMIM 611761) encoding lipase maturation factor 1 [<xref rid="R62" ref-type="bibr">62</xref>,<xref rid="R65" ref-type="bibr">65</xref>]. In contrast, multifactorial chylomicronemia syndrome is a non-Mendelian complex genetic disorder associated with either: heterozygosity for a pathogenic variant in one of the above five genes, seen in 15&#8211;20% of affected subjects [<xref rid="R65" ref-type="bibr">65</xref>]; or polygenic predisposition due to aggregated weak effect SNP loci in up to 50% of affected individuals [<xref rid="R62" ref-type="bibr">62</xref>,<xref rid="R65" ref-type="bibr">65</xref>].</p><p>The lifetime relative risk of pancreatitis is 70&#8211;80% in familial chylomicronemia syndrome compared to 20&#8211;30% in multifactorial chylomicronemia syndrome [<xref rid="R66" ref-type="bibr">66</xref>]. This likely reflects a lifetime of sustained refractory extreme severity of chylomicronemia in the former condition [<xref rid="R66" ref-type="bibr">66</xref>]. There is other evidence that increased genetic burden for hypertriglyceridemia is associated with pancreatitis.</p><p>For instance, Deshotels <italic toggle="yes">et al.</italic>[<xref rid="R67" ref-type="bibr">67</xref>] recently reported a study in 363 lipid clinic patients of whom 176, 129 and 58 had triglyceride levels &lt;2.3&#8202;mmol/l (&lt;200&#8202;mg/dl), 2.3&#8211;11.1&#8202;mmol/l (200&#8211;999&#8202;mg/dl) and &gt;11.1&#8202;mmol/l (&gt;1000&#8202;mg/dl), respectively. Patients were genotyped for rare pathogenic variants in <italic toggle="yes">LPL</italic>, <italic toggle="yes">APOC2</italic>, <italic toggle="yes">APOA5</italic>, <italic toggle="yes">GPIHBP1</italic> and <italic toggle="yes">LMF1</italic> as well as for a polygenic score for high triglyceride levels. The authors found that three and 34 patients had familial and multifactorial chylomicronemia syndrome, respectively. Also, 59 patients had a high pathogenic score for triglycerides whereas 20 patients had both a heterozygous pathogenic variant and a high polygenic score. The main findings were confined to pancreatitis risk in patients with the most severe triglyceride elevation. Specifically, of 37 individuals with a history of acute pancreatitis, 35 were in the subgroup with triglyceride &gt;11.1&#8202;mmol/l. Compared with those who had neither a pathogenic variant nor a high polygenic score, the authors observed that those with either a pathogenic variant or a high polygenic risk score had no increased risk of acute pancreatitis, but those with both a pathogenic variant and a high polygenic risk score had higher triglycerides and five-fold increased risk of pancreatitis compared to all others [<xref rid="R67" ref-type="bibr">67</xref>]. The authors concluded that hypertriglyceridemic patients with both a heterozygous rare pathogenic variant and a high polygenic score had extremely high pancreatitis risk and were candidates for closer medical attention [<xref rid="R67" ref-type="bibr">67</xref>]. In contrast, in a study of two cohorts of lipid clinic patients with fasting triglyceride &gt;10&#8202;mmol/l, we found no increased risk of pancreatitis in those with both a heterozygous rare pathogenic variant plus high polygenic score, compared with either genetic factor alone [<xref rid="R68" ref-type="bibr">68</xref>]. Studies in prospective epidemiologic cohorts could help define additivity of genetic factors.</p><p>Severe HTG has also been observed in individuals with familial partial lipodystrophy (FLPD) subtype 2 caused by pathogenic rare variants in <italic toggle="yes">LMNA</italic> (OMIM 150330) encoding nuclear lamin A/C [<xref rid="R69" ref-type="bibr">69</xref>]. In these patients, hypertriglyceridemia severity is typically mild-to-moderate. However, about 15% of patients experience sustained severe hypertriglyceridemia &gt;10&#8202;mmol/l and this subgroup has a very high lifetime risk of acute pancreatitis, emphasizing again that irrespective of the genetic background, the proximal determinant of pancreatitis risk is the severity of the triglyceride elevation [<xref rid="R69" ref-type="bibr">69</xref>].</p></sec><sec sec-type="subjects"><title>GENETIC DETERMINANTS OF PANCREATITIS RISK IN PATIENTS WITH HYPERTRIGLYCERIDEMIA</title><p>We could find no reports in which genetic determinants of pancreatitis were studied in patients with hypertriglyceridemia. However, an analogous study in patients with alcohol use provides a possible framework. Specifically, Rosendahl <italic toggle="yes">et al.</italic>[<xref rid="R27" ref-type="bibr">27</xref>] reported that the top five significant gene loci in European patients with alcohol-associated chronic pancreatitis (significant odds ratios shown) were: <italic toggle="yes">SPINK1</italic> 3.82, <italic toggle="yes">CLND2-MORC4</italic> 2.57, <italic toggle="yes">PRSS1-PRSS2</italic> 1.84; <italic toggle="yes">CTRC</italic> 1.83; and <italic toggle="yes">CTRB1-CRTB2</italic> 1.35. It would be important to determine whether these loci similarly provide association signals in a GWAS performed in patients with hypertriglyceridemia.</p></sec><sec sec-type="summary"><title>SUMMARY AND INTERPRETATION</title><p>There is a complex interaction between genetic, environmental, patient-specific and other risk factors underlying pancreatitis risk (see Fig. <xref rid="F1" ref-type="fig">1</xref>). Most cases of unexplained pancreatitis are not fully accounted for by genetic determinants. Exceptions include high penetrance variants in <italic toggle="yes">PRSS1</italic> and <italic toggle="yes">SPINK1</italic>. Expression may also be influenced by gene&#8211;gene and gene&#8211;environment interactions. Additionally, risk states for pancreatitis such as gallstones have their own genetic determinants.</p><fig position="float" id="F1" orientation="portrait"><label>FIGURE 1</label><caption><p>Overview of genetic determinants of pancreatitis in the context of hypertriglyceridemia. Three general categories of genetic determinants are shown. Genetic determinants of hypertriglyceridemia include: biallelic pathogenic rare variants in the indicated genes causing familial chylomicronemia syndrome; heterozygous or single copy of these pathogenic variants, which are incompletely penetrant and predispose to rather than cause hypertriglyceridemia; and common single nucleotide polymorphisms (SNPs), which act additively to increase predisposition to hypertriglyceridemia but are not causative. Genetic determinants of pancreatitis itself include: pathogenic rare variants in the indicated genes causing hereditary pancreatitis; heterozygous or single copy of these pathogenic variants, which are incompletely penetrant and predispose to rather than cause pancreatitis; and common SNPs that predisposition to pancreatitis but are not causative. We could not find polygenic risk scores for pancreatitis comprised of such SNPs. Genetic determinants of pancreatitis risk factors or precipitating factors other than hypertriglyceridemia include polygenic risk comprised of small effect SNPs that increase susceptibility to gallstones, hypercalcemia, and diabetes as well as alcohol use and smoking.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="colip-34-59-g002.jpg"/></fig><p>For a patient with severe hypertriglyceridemia, do genetic factors predict risk of pancreatitis? First, biallelic pathogenic variants underlying Mendelian familial chylomicronemia syndrome are associated with greater lifetime risk of pancreatitis compared with other genotypes associated with complex multifactorial chylomicronemia syndrome. Second, among those with multifactorial chylomicronemia, the combination of both high polygenic risk from common triglyceride-associated variants plus a single copy of a pathogenic triglyceride-associated variant is much higher than among individuals with only one or none of these genetic determinants. Third, while it is tempting to speculate that inter-individual variation in pancreatitis risk in patients with severe hypertriglyceridemia is modulated by pancreatitis-associated gene loci, there is no evidence for this at present. Fourth, the most reliable clinical marker of pancreatitis risk currently is the degree of triglyceride elevation rather than the patient's genotype. Definitive answers await direct proof of genetic modulators of pancreatitis risk among patients with severe hypertriglyceridemia.</p></sec><sec sec-type="conclusion"><title>CONCLUSION</title><p>The value of a genetic diagnosis for evaluating pancreatitis risk in hypertriglyceridemia is currently unclear. However, theoretical benefits to genotyping include: providing patients with the certainty of a diagnosis; allowing for targeted familial screening; more accurate clinical prognostication and engagement of genetic counselors for family planning; tailored monitoring for any associated manifestations; and a greater understanding of the underlying pathophysiology that may eventually lead better treatments. An understanding of genetic risk may also influence eligibility and timing of interventions. At a minimum, individuals identified to carry high genetic risk should be counseled regarding avoidance of other pancreatitis triggers, such as smoking or alcohol. Furthermore, proactive dietary modification may be helpful, especially in those with familial chylomicronemia syndrome, who might also benefit from new pharmacologic treatments [<xref rid="R70" ref-type="bibr">70</xref>].</p></sec><sec><title>Acknowledgements</title><p>
<italic toggle="yes">None.</italic>
</p><sec><title>Financial support and sponsorship</title><p>
<italic toggle="yes">R.A.H. is supported by the Jacob J. Wolfe Distinguished Medical Research Chair, the Edith Schulich Vinet Research Chair, and the Martha G. Blackburn Chair in Cardiovascular Research. R.A.H. holds operating grants from the Canadian Institutes of Health Research (Foundation award), the Heart and Stroke Foundation of Ontario (G-21-0031455) and the Academic Medical Association of Southwestern Ontario (INN21-011).</italic>
</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest</title><p>
<italic toggle="yes">R.A.H. reports consulting fees from Acasti, Aegerion, Akcea/Ionis, Amgen, Boston Heart, HLS Therapeutics, Novartis, Pfizer, Regeneron, Sanofi and Ultragenyx.</italic>
</p></sec></sec></body><back><sec><title>REFERENCES AND RECOMMENDED READING</title><p>Papers of particular interest, published within the annual period of review, have been highlighted as:</p><list list-type="simple"><list-item><p>&#9642; of special interest</p></list-item><list-item><p>&#9642;&#9642; of outstanding interest</p></list-item></list></sec><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laufs</surname><given-names>U</given-names></name><name name-style="western"><surname>Parhofer</surname><given-names>KG</given-names></name><name name-style="western"><surname>Ginsberg</surname><given-names>HN</given-names></name><name name-style="western"><surname>Hegele</surname><given-names>RA</given-names></name></person-group>. <article-title>Clinical review on triglycerides</article-title>. <source>Eur Heart J</source><year>2020</year>; <volume>41</volume>:<fpage>99</fpage>&#8211;<lpage>109</lpage>.<pub-id pub-id-type="pmid">31764986</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/ehz785</pub-id><pub-id pub-id-type="pmcid">PMC6938588</pub-id></mixed-citation></ref><ref id="R2"><label>2&#9642;</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Papachristou</surname><given-names>GI</given-names></name></person-group>. <article-title>New insights into acute pancreatitis</article-title>. <source>Nat Rev Gastroenterol Hepatol</source><year>2019</year>; <volume>16</volume>:<fpage>479</fpage>&#8211;<lpage>496</lpage>.<pub-id pub-id-type="pmid">31138897</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41575-019-0158-2</pub-id></mixed-citation><note><p>Summary of recent advances in acute pancreatitis, focusing on pathophysiology as well as clinical management.</p></note></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peery</surname><given-names>AF</given-names></name><name name-style="western"><surname>Crockett</surname><given-names>SD</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>CC</given-names></name><etal/></person-group>. <article-title>Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update</article-title>. <source>Gastroenterology</source><year>2022</year>; <volume>162</volume>:<fpage>621</fpage>&#8211;<lpage>644</lpage>.<pub-id pub-id-type="pmid">34678215</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2021.10.017</pub-id><pub-id pub-id-type="pmcid">PMC10756322</pub-id></mixed-citation></ref><ref id="R4"><label>4&#9642;&#9642;</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>FU</given-names></name><name name-style="western"><surname>Laemmerhirt</surname><given-names>F</given-names></name><name name-style="western"><surname>Lerch</surname><given-names>MM</given-names></name></person-group>. <article-title>Acute pancreatitis: genetic risk and clinical implications</article-title>. <source>J Clin Med</source><year>2021</year>; <volume>10</volume>:<fpage>190</fpage>.<pub-id pub-id-type="pmid">33430357</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcm10020190</pub-id><pub-id pub-id-type="pmcid">PMC7825757</pub-id></mixed-citation><note><p>An up to date review encompassing genetic predisposition in different etiologies of acute pancreatitis and genetic factors influencing course of pancreatitis. Also reviews indications for and clinical implications of genetic testing.</p></note></ref><ref id="R5"><label>5&#9642;</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>FU</given-names></name><name name-style="western"><surname>Skube</surname><given-names>ME</given-names></name><name name-style="western"><surname>Lerch</surname><given-names>MM</given-names></name></person-group>. <article-title>Chronic pancreatitis: an update on genetic risk factors</article-title>. <source>Curr Opin Gastroenterol</source><year>2018</year>; <volume>34</volume>:<fpage>322</fpage>&#8211;<lpage>329</lpage>.<pub-id pub-id-type="pmid">29901518</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MOG.0000000000000461</pub-id><pub-id pub-id-type="pmcid">PMC9622341</pub-id></mixed-citation><note><p>A very good resource focusing on chronic pancreatitis etiology and genetic risk.</p></note></ref><ref id="R6"><label>6&#9642;</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>FU</given-names></name><name name-style="western"><surname>Laemmerhirt</surname><given-names>F</given-names></name><name name-style="western"><surname>Lerch</surname><given-names>MM</given-names></name></person-group>. <article-title>Etiology and risk factors of acute and chronic pancreatitis</article-title>. <source>Visc Med</source><year>2019</year>; <volume>35</volume>:<fpage>73</fpage>&#8211;<lpage>81</lpage>.<pub-id pub-id-type="pmid">31192240</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000499138</pub-id><pub-id pub-id-type="pmcid">PMC6514487</pub-id></mixed-citation><note><p>A very good resource for both acute and chronic pancreatitis etiology and genetic risk.</p></note></ref><ref id="R7"><label>7&#9642;&#9642;</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayerle</surname><given-names>J</given-names></name><name name-style="western"><surname>Sendler</surname><given-names>M</given-names></name><name name-style="western"><surname>Hegyi</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Genetics, cell biology, and pathophysiology of pancreatitis</article-title>. <source>Gastroenterology</source><year>2019</year>; <volume>156</volume>:<fpage>1951</fpage>&#8211;<lpage>1968</lpage>.<pub-id pub-id-type="pmid">30660731</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2018.11.081</pub-id><pub-id pub-id-type="pmcid">PMC6903413</pub-id></mixed-citation><note><p>An excellent recent review of genetic risk factors in chronic pancreatitis as well as pathways for risk, also reviews roles of proteases in the pathophysiology of pancreatitis.</p></note></ref><ref id="R8"><label>8&#9642;</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wertheim-Tysarowska</surname><given-names>K</given-names></name><name name-style="western"><surname>Oracz</surname><given-names>G</given-names></name><name name-style="western"><surname>Rygiel</surname><given-names>AM</given-names></name></person-group>. <article-title>Genetic risk factors in early-onset nonalcoholic chronic pancreatitis: an update</article-title>. <source>Genes (Basel)</source><year>2021</year>; <volume>12</volume>:<fpage>785</fpage>.<pub-id pub-id-type="pmid">34065437</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/genes12050785</pub-id><pub-id pub-id-type="pmcid">PMC8160726</pub-id></mixed-citation><note><p>A superior review focusing on nonalcohol related chronic pancreatitis etiology and genetic risk.</p></note></ref><ref id="R9"><label>9&#9642;</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>M</given-names></name><name name-style="western"><surname>Minowa</surname><given-names>K</given-names></name><name name-style="western"><surname>Nakano</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Genetic abnormalities in pancreatitis: an update on diagnosis, clinical features, and treatment</article-title>. <source>Diagnostics (Basel)</source><year>2020</year>; <volume>11</volume>:<fpage>31</fpage>.<pub-id pub-id-type="pmid">33375361</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/diagnostics11010031</pub-id><pub-id pub-id-type="pmcid">PMC7824215</pub-id></mixed-citation><note><p>A helpful overview on genetic determinants of chronic pancreatitis.</p></note></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richards</surname><given-names>S</given-names></name><name name-style="western"><surname>Aziz</surname><given-names>N</given-names></name><name name-style="western"><surname>Bale</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source>Genet Med</source><year>2015</year>; <volume>17</volume>:<fpage>405</fpage>&#8211;<lpage>424</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/gim.2015.30</pub-id><pub-id pub-id-type="pmcid">PMC4544753</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masson</surname><given-names>E</given-names></name><name name-style="western"><surname>Zou</surname><given-names>WB</given-names></name><name name-style="western"><surname>G&#233;nin</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Expanding ACMG variant classification guidelines into a general framework</article-title>. <source>Hum Genomics</source><year>2022</year>; <volume>16</volume>:<fpage>31</fpage>.<pub-id pub-id-type="pmid">35974416</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40246-022-00407-x</pub-id><pub-id pub-id-type="pmcid">PMC9380380</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giefer</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Lowe</surname><given-names>ME</given-names></name><name name-style="western"><surname>Werlin</surname><given-names>SL</given-names></name><etal/></person-group>. <article-title>Early-onset acute recurrent and chronic pancreatitis is associated with PRSS1 or CTRC gene mutations</article-title>. <source>J Pediatr</source><year>2017</year>; <volume>186</volume>:<fpage>95</fpage>&#8211;<lpage>100</lpage>.<pub-id pub-id-type="pmid">28502372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpeds.2017.03.063</pub-id><pub-id pub-id-type="pmcid">PMC5506853</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muller</surname><given-names>N</given-names></name><name name-style="western"><surname>Sarantitis</surname><given-names>I</given-names></name><name name-style="western"><surname>Rouanet</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Natural history of SPINK1 germline mutation related-pancreatitis</article-title>. <source>EBioMedicine</source><year>2019</year>; <volume>48</volume>:<fpage>581</fpage>&#8211;<lpage>591</lpage>.<pub-id pub-id-type="pmid">31628023</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ebiom.2019.09.032</pub-id><pub-id pub-id-type="pmcid">PMC6838417</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>SM</given-names></name><name name-style="western"><surname>Shin</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee KA</surname></name></person-group>. <article-title>PRSS1, SPINK1, CFTR, and CTRC pathogenic variants in korean patients with idiopathic pancreatitis</article-title>. <source>Ann Lab Med</source><year>2016</year>; <volume>36</volume>:<fpage>555</fpage>&#8211;<lpage>560</lpage>.<pub-id pub-id-type="pmid">27578509</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3343/alm.2016.36.6.555</pub-id><pub-id pub-id-type="pmcid">PMC5011109</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zou</surname><given-names>WB</given-names></name><name name-style="western"><surname>Tang</surname><given-names>XY</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>DZ</given-names></name><etal/></person-group>. <article-title>SPINK1, PRSS1, CTRC, and CFTR genotypes influence disease onset and clinical outcomes in chronic pancreatitis</article-title>. <source>Clin Transl Gastroenterol</source><year>2018</year>; <volume>9</volume>:<fpage>204</fpage>.<pub-id pub-id-type="pmid">30420730</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41424-018-0069-5</pub-id><pub-id pub-id-type="pmcid">PMC6232107</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pu</surname><given-names>N</given-names></name><name name-style="western"><surname>Masson</surname><given-names>E</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>DN</given-names></name><etal/></person-group>. <article-title>Chronic pancreatitis: the true pathogenic culprit within the SPINK1 N34S-containing haplotype is no longer at large</article-title>. <source>Genes (Basel)</source><year>2021</year>; <volume>12</volume>:<fpage>1683</fpage>.<pub-id pub-id-type="pmid">34828289</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/genes12111683</pub-id><pub-id pub-id-type="pmcid">PMC8619230</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Witt</surname><given-names>H</given-names></name><name name-style="western"><surname>Beer</surname><given-names>S</given-names></name><name name-style="western"><surname>Rosendahl</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Variants in CPA1 are strongly associated with early onset chronic pancreatitis</article-title>. <source>Nat Genet</source><year>2013</year>; <volume>45</volume>:<fpage>1216</fpage>&#8211;<lpage>1220</lpage>.<pub-id pub-id-type="pmid">23955596</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ng.2730</pub-id><pub-id pub-id-type="pmcid">PMC3909499</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kujko</surname><given-names>AA</given-names></name><name name-style="western"><surname>Berki</surname><given-names>DM</given-names></name><name name-style="western"><surname>Oracz</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>A novel p.Ser282Pro CPA1 variant is associated with autosomal dominant hereditary pancreatitis</article-title>. <source>Gut</source><year>2017</year>; <volume>66</volume>:<fpage>1728</fpage>&#8211;<lpage>1730</lpage>.<pub-id pub-id-type="pmid">28258133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2017-313816</pub-id><pub-id pub-id-type="pmcid">PMC5933945</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nemeth</surname><given-names>BC</given-names></name><name name-style="western"><surname>Orekhova</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Novel p.K374E variant of CPA1 causes misfolding-induced hereditary pancreatitis with autosomal dominant inheritance</article-title>. <source>Gut</source><year>2020</year>; <volume>69</volume>:<fpage>790</fpage>&#8211;<lpage>792</lpage>.<pub-id pub-id-type="pmid">31005883</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2019-318751</pub-id><pub-id pub-id-type="pmcid">PMC8596457</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>JH</given-names></name><name name-style="western"><surname>Boulling</surname><given-names>A</given-names></name><name name-style="western"><surname>Masson</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Most unambiguous loss-of-function CPA1 mutations are unlikely to predispose to chronic pancreatitis</article-title>. <source>Gut</source><year>2020</year>; <volume>69</volume>:<fpage>785</fpage>&#8211;<lpage>786</lpage>.<pub-id pub-id-type="pmid">30862690</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2019-318564</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fjeld</surname><given-names>K</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>FU</given-names></name><name name-style="western"><surname>Lasher</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>A recombined allele of the lipase gene CEL and its pseudogene CELP confers susceptibility to chronic pancreatitis</article-title>. <source>Nat Genet</source><year>2015</year>; <volume>47</volume>:<fpage>518</fpage>&#8211;<lpage>522</lpage>.<pub-id pub-id-type="pmid">25774637</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ng.3249</pub-id><pub-id pub-id-type="pmcid">PMC5321495</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fjeld</surname><given-names>K</given-names></name><name name-style="western"><surname>Gravdal</surname><given-names>A</given-names></name><name name-style="western"><surname>Brekke</surname><given-names>RS</given-names></name><etal/></person-group>. <article-title>The genetic risk factor CEL-HYB1 causes proteotoxicity and chronic pancreatitis in mice</article-title>. <source>Pancreatology</source><year>2022</year>; <volume>22</volume>:<fpage>1099</fpage>&#8211;<lpage>1111</lpage>.<pub-id pub-id-type="pmid">36379850</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pan.2022.11.003</pub-id><pub-id pub-id-type="pmcid">PMC11157984</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zou</surname><given-names>WB</given-names></name><name name-style="western"><surname>Boulling</surname><given-names>A</given-names></name><name name-style="western"><surname>Masamune</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>No association between CEL-HYB hybrid allele and chronic pancreatitis in Asian populations</article-title>. <source>Gastroenterology</source><year>2016</year>; <volume>150</volume>:<fpage>1558</fpage>&#8211;<lpage>1560</lpage>.<pub-id pub-id-type="pmid">26946345</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2016.02.071</pub-id><pub-id pub-id-type="pmcid">PMC5380763</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hegyi</surname><given-names>P</given-names></name><name name-style="western"><surname>Wilschanski</surname><given-names>M</given-names></name><name name-style="western"><surname>Muallem</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>CFTR: A new horizon in the pathomechanism and treatment of pancreatitis</article-title>. <source>Rev Physiol Biochem Pharmacol</source><year>2016</year>; <volume>170</volume>:<fpage>37</fpage>&#8211;<lpage>66</lpage>.<pub-id pub-id-type="pmid">26856995</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/112_2015_5002</pub-id><pub-id pub-id-type="pmcid">PMC5232416</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masson</surname><given-names>E</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JM</given-names></name><name name-style="western"><surname>Audrezet</surname><given-names>MP</given-names></name><etal/></person-group>. <article-title>A conservative assessment of the major genetic causes of idiopathic chronic pancreatitis: data from a comprehensive analysis of PRSS1, SPINK1, CTRC and CFTR genes in 253 young French patients</article-title>. <source>PLoS One</source><year>2013</year>; <volume>8</volume>:<fpage>e73522</fpage>.<pub-id pub-id-type="pmid">23951356</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0073522</pub-id><pub-id pub-id-type="pmcid">PMC3738529</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dron</surname><given-names>JS</given-names></name><name name-style="western"><surname>Hegele</surname><given-names>RA</given-names></name></person-group>. <article-title>The evolution of genetic-based risk scores for lipids and cardiovascular disease</article-title>. <source>Curr Opin Lipidol</source><year>2019</year>; <volume>30</volume>:<fpage>71</fpage>&#8211;<lpage>81</lpage>.<pub-id pub-id-type="pmid">30676533</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MOL.0000000000000576</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosendahl</surname><given-names>J</given-names></name><name name-style="western"><surname>Kirsten</surname><given-names>H</given-names></name><name name-style="western"><surname>Hegyi</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and nonalcoholic chronic pancreatitis</article-title>. <source>Gut</source><year>2018</year>; <volume>67</volume>:<fpage>1855</fpage>&#8211;<lpage>1863</lpage>.<pub-id pub-id-type="pmid">28754779</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2017-314454</pub-id><pub-id pub-id-type="pmcid">PMC6145291</pub-id></mixed-citation></ref><ref id="R28"><label>28&#9642;</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>AW</given-names></name><name name-style="western"><surname>K&#252;hnapfel</surname><given-names>A</given-names></name><name name-style="western"><surname>Kirsten</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Colocalization analysis of pancreas eQTLs with risk loci from alcoholic and novel nonalcoholic chronic pancreatitis GWAS suggests potential disease causing mechanisms</article-title>. <source>Pancreatology</source><year>2022</year>; <volume>22</volume>:<fpage>449</fpage>&#8211;<lpage>456</lpage>.<pub-id pub-id-type="pmid">35331647</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pan.2022.03.007</pub-id></mixed-citation><note><p>An interesting genome-wide association study that combines expression analysis in pancreatic cells, and confirms several known loci.</p></note></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitcomb</surname><given-names>DC</given-names></name><name name-style="western"><surname>LaRusch</surname><given-names>J</given-names></name><name name-style="western"><surname>Krasinskas</surname><given-names>AM</given-names></name><etal/></person-group>. <article-title>Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis</article-title>. <source>Nat Genet</source><year>2012</year>; <volume>44</volume>:<fpage>1349</fpage>&#8211;<lpage>1354</lpage>.<pub-id pub-id-type="pmid">23143602</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ng.2466</pub-id><pub-id pub-id-type="pmcid">PMC3510344</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name></person-group>. <article-title>Effects of PRSS1-PRSS2 rs10273639, CLDN2 rs7057398 and MORC4 rs12688220 polymorphisms on individual susceptibility to pancreatitis: a meta-analysis</article-title>. <source>Genomics</source><year>2020</year>; <volume>112</volume>:<fpage>848</fpage>&#8211;<lpage>852</lpage>.<pub-id pub-id-type="pmid">31163246</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ygeno.2019.05.025</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>XY</given-names></name><name name-style="western"><surname>Zou</surname><given-names>WB</given-names></name><name name-style="western"><surname>Masson</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>The CTRB1-CTRB2 risk allele for chronic pancreatitis discovered in European populations does not contribute to disease risk variation in the Chinese population due to near allele fixation</article-title>. <source>Gut</source><year>2018</year>; <volume>67</volume>:<fpage>1368</fpage>&#8211;<lpage>1369</lpage>.<pub-id pub-id-type="pmid">28951524</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2017-315180</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seltsam</surname><given-names>K</given-names></name><name name-style="western"><surname>Pentner</surname><given-names>C</given-names></name><name name-style="western"><surname>Weigl</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Sequencing of the complex CTRB1-CTRB2 locus in chronic pancreatitis</article-title>. <source>Pancreatology</source><year>2020</year>; <volume>20</volume>:<fpage>1598</fpage>&#8211;<lpage>1603</lpage>.<pub-id pub-id-type="pmid">33036922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pan.2020.09.017</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>FU</given-names></name><name name-style="western"><surname>Schurmann</surname><given-names>C</given-names></name><name name-style="western"><surname>Guenther</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Fucosyltransferase 2 (FUT2) nonsecretor status and blood group B are associated with elevated serum lipase activity in asymptomatic subjects, and an increased risk for chronic pancreatitis: a genetic association study</article-title>. <source>Gut</source><year>2015</year>; <volume>64</volume>:<fpage>646</fpage>&#8211;<lpage>656</lpage>.<pub-id pub-id-type="pmid">25028398</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2014-306930</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hwang</surname><given-names>CS</given-names></name><name name-style="western"><surname>Sukalo</surname><given-names>M</given-names></name><name name-style="western"><surname>Batygin</surname><given-names>O</given-names></name><etal/></person-group>. <article-title>Ubiquitin ligases of the N-end rule pathway: assessment of mutations in UBR1 that cause the Johanson-Blizzard syndrome</article-title>. <source>PLoS One</source><year>2011</year>; <volume>6</volume>:<fpage>e24925</fpage>.<pub-id pub-id-type="pmid">21931868</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0024925</pub-id><pub-id pub-id-type="pmcid">PMC3172311</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masamune</surname><given-names>A</given-names></name><name name-style="western"><surname>Nakano</surname><given-names>E</given-names></name><name name-style="western"><surname>Niihori</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Variants in the UBR1 gene are not associated with chronic pancreatitis in Japan</article-title>. <source>Pancreatology</source><year>2016</year>; <volume>16</volume>:<fpage>814</fpage>&#8211;<lpage>818</lpage>.<pub-id pub-id-type="pmid">27397733</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pan.2016.06.662</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sciskalska</surname><given-names>M</given-names></name><name name-style="western"><surname>Oldakowska</surname><given-names>M</given-names></name><name name-style="western"><surname>Marek</surname><given-names>G</given-names></name><name name-style="western"><surname>Milnerowicz</surname><given-names>H</given-names></name></person-group>. <article-title>Increased risk of acute pancreatitis occurrence in smokers with rs5751901 polymorphisms in GGT1 gene</article-title>. <source>Int J Med Sci</source><year>2020</year>; <volume>17</volume>:<fpage>242</fpage>&#8211;<lpage>254</lpage>.<pub-id pub-id-type="pmid">32038108</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/ijms.38657</pub-id><pub-id pub-id-type="pmcid">PMC6990886</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lasher</surname><given-names>D</given-names></name><name name-style="western"><surname>Szabo</surname><given-names>A</given-names></name><name name-style="western"><surname>Masamune</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Protease-sensitive pancreatic lipase variants are associated with early onset chronic pancreatitis</article-title>. <source>Am J Gastroenterol</source><year>2019</year>; <volume>114</volume>:<fpage>974</fpage>&#8211;<lpage>983</lpage>.<pub-id pub-id-type="pmid">30789418</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.14309/ajg.0000000000000051</pub-id><pub-id pub-id-type="pmcid">PMC6624845</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>PC</given-names></name><name name-style="western"><surname>Cortez</surname><given-names>JT</given-names></name><name name-style="western"><surname>Chamberlain</surname><given-names>CE</given-names></name><etal/></person-group>. <article-title>Elastase 3B mutation links to familial pancreatitis with diabetes and pancreatic adenocarcinoma</article-title>. <source>J Clin Invest</source><year>2019</year>; <volume>129</volume>:<fpage>4676</fpage>&#8211;<lpage>4681</lpage>.<pub-id pub-id-type="pmid">31369399</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI129961</pub-id><pub-id pub-id-type="pmcid">PMC6819098</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toth</surname><given-names>A</given-names></name><name name-style="western"><surname>Demcsak</surname><given-names>A</given-names></name><name name-style="western"><surname>Zankl</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Loss-of-function variant in chymotrypsin like elastase 3B (CELA3B) is associated with nonalcoholic chronic pancreatitis</article-title>. <source>Pancreatology</source><year>2022</year>; <volume>22</volume>:<fpage>713</fpage>&#8211;<lpage>718</lpage>.<pub-id pub-id-type="pmid">35773178</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pan.2022.06.258</pub-id><pub-id pub-id-type="pmcid">PMC9474678</pub-id></mixed-citation></ref><ref id="R40"><label>40&#9642;&#9642;</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van den Berg</surname><given-names>FF</given-names></name><name name-style="western"><surname>Kempeneers</surname><given-names>MA</given-names></name><name name-style="western"><surname>van Santvoort</surname><given-names>HC</given-names></name><etal/></person-group>. <article-title>Meta-analysis and field synopsis of genetic variants associated with the risk and severity of acute pancreatitis</article-title>. <source>BJS Open</source><year>2020</year>; <volume>4</volume>:<fpage>3</fpage>&#8211;<lpage>15</lpage>.<pub-id pub-id-type="pmid">32011822</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/bjs5.50231</pub-id><pub-id pub-id-type="pmcid">PMC6996643</pub-id></mixed-citation><note><p>An excellent systematic review looking at evidence for candidate gene associations with acute pancreatitis.</p></note></ref><ref id="R41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#700; Oliveira Martins</surname><given-names>F</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>BC</given-names></name><name name-style="western"><surname>Rodrigues</surname><given-names>AS</given-names></name><name name-style="western"><surname>Rueff</surname><given-names>J</given-names></name></person-group>. <article-title>Genetic susceptibility in acute pancreatitis: genotyping of GSTM1, GSTT1, GSTP1, CASP7, CASP8, CASP9, CASP10, LTA, TNFRSF1B, and TP53 gene variants</article-title>. <source>Pancreas</source><year>2017</year>; <volume>46</volume>:<fpage>71</fpage>&#8211;<lpage>76</lpage>.<pub-id pub-id-type="pmid">27984487</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MPA.0000000000000707</pub-id></mixed-citation></ref><ref id="R42"><label>42&#9642;&#9642;</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>S</given-names></name><name name-style="western"><surname>Giovannucci</surname><given-names>EL</given-names></name><name name-style="western"><surname>Larsson SC</surname></name></person-group>. <article-title>Gallstone disease, diabetes, calcium, triglycerides, smoking and alcohol consumption and pancreatitis risk: Mendelian randomization study</article-title>. <source>NPJ Genom Med</source><year>2021</year>; <volume>6</volume>:<fpage>27</fpage>.<pub-id pub-id-type="pmid">33782414</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41525-021-00189-6</pub-id><pub-id pub-id-type="pmcid">PMC8007637</pub-id></mixed-citation><note><p>An informative proof-of-concept study that uses the powerful approach of Mendelian randomization to show how genetic determinants of pancreatitis risk factors also directly determine pancreatitis risk.</p></note></ref><ref id="R43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferkingstad</surname><given-names>E</given-names></name><name name-style="western"><surname>Oddsson</surname><given-names>A</given-names></name><name name-style="western"><surname>Gretarsdottir</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>K. Genome-wide association meta-analysis yields 20 loci associated with gallstone disease</article-title>. <source>Nat Commun</source><year>2018</year>; <volume>9</volume>:<fpage>5101</fpage>.<pub-id pub-id-type="pmid">30504769</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-018-07460-y</pub-id><pub-id pub-id-type="pmcid">PMC6269469</pub-id></mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wedow</surname><given-names>R</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use</article-title>. <source>Nat Genet</source><year>2019</year>; <volume>51</volume>:<fpage>237</fpage>&#8211;<lpage>244</lpage>.<pub-id pub-id-type="pmid">30643251</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41588-018-0307-5</pub-id><pub-id pub-id-type="pmcid">PMC6358542</pub-id></mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vujkovic</surname><given-names>M</given-names></name><name name-style="western"><surname>Keaton</surname><given-names>JM</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>JA</given-names></name><etal/></person-group>. <article-title>Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multiancestry meta-analysis</article-title>. <source>Nat Genet</source><year>2020</year>; <volume>52</volume>:<fpage>680</fpage>&#8211;<lpage>691</lpage>.<pub-id pub-id-type="pmid">32541925</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41588-020-0637-y</pub-id><pub-id pub-id-type="pmcid">PMC7343592</pub-id></mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Seaghdha</surname><given-names>CM</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations</article-title>. <source>PLoS Genet</source><year>2013</year>; <volume>9</volume>:<fpage>e1003796</fpage>.<pub-id pub-id-type="pmid">24068962</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pgen.1003796</pub-id><pub-id pub-id-type="pmcid">PMC3778004</pub-id></mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richardson</surname><given-names>TG</given-names></name><name name-style="western"><surname>Sanderson</surname><given-names>E</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>TM</given-names></name><etal/></person-group>. <article-title>Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis</article-title>. <source>PLoS Med</source><year>2020</year>; <volume>17</volume>:<fpage>e1003062</fpage>.<pub-id pub-id-type="pmid">32203549</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pmed.1003062</pub-id><pub-id pub-id-type="pmcid">PMC7089422</pub-id></mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hegele</surname><given-names>RA</given-names></name></person-group>. <article-title>Editorial comment: when Mendelian randomization goes astray</article-title>. <source>Curr Opin Lipidol</source><year>2021</year>; <volume>32</volume>:<fpage>79</fpage>&#8211;<lpage>80</lpage>.<pub-id pub-id-type="pmid">33399354</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MOL.0000000000000735</pub-id></mixed-citation></ref><ref id="R49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lankisch</surname><given-names>PG</given-names></name><name name-style="western"><surname>Apte</surname><given-names>M</given-names></name><name name-style="western"><surname>Banks</surname><given-names>PA</given-names></name></person-group>. <article-title>Acute pancreatitis</article-title>. <source>Lancet</source><year>2015</year>; <volume>386</volume>:<fpage>85</fpage>&#8211;<lpage>96</lpage>.<pub-id pub-id-type="pmid">25616312</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(14)60649-8</pub-id></mixed-citation></ref><ref id="R50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walker</surname><given-names>MD</given-names></name><name name-style="western"><surname>Shane</surname><given-names>E</given-names></name></person-group>. <article-title>Hypercalcemia: a review</article-title>. <source>JAMA</source><year>2022</year>; <volume>328</volume>:<fpage>1624</fpage>&#8211;<lpage>1636</lpage>.<pub-id pub-id-type="pmid">36282253</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2022.18331</pub-id></mixed-citation></ref><ref id="R51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minisola</surname><given-names>S</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>A</given-names></name><name name-style="western"><surname>Belaya</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism</article-title>. <source>J Bone Miner Res</source><year>2022</year>; <volume>37</volume>:<fpage>2315</fpage>&#8211;<lpage>2329</lpage>.<pub-id pub-id-type="pmid">36245271</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jbmr.4665</pub-id><pub-id pub-id-type="pmcid">PMC10092691</pub-id></mixed-citation></ref><ref id="R52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Felderbauer</surname><given-names>P</given-names></name><name name-style="western"><surname>Klein</surname><given-names>W</given-names></name><name name-style="western"><surname>Bulut</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Mutations in the calcium-sensing receptor: a new genetic risk factor for chronic pancreatitis?</article-title><source>Scand J Gastroenterol</source><year>2006</year>; <volume>41</volume>:<fpage>343</fpage>&#8211;<lpage>348</lpage>.<pub-id pub-id-type="pmid">16497624</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/00365520510024214</pub-id></mixed-citation></ref><ref id="R53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muddana</surname><given-names>V</given-names></name><name name-style="western"><surname>Lamb</surname><given-names>J</given-names></name><name name-style="western"><surname>Greer</surname><given-names>JB</given-names></name><etal/></person-group>. <article-title>Association between calcium sensing receptor gene polymorphisms and chronic pancreatitis in a US population: role of serine protease inhibitor Kazal 1type and alcohol</article-title>. <source>World J Gastroenterol</source><year>2008</year>; <volume>14</volume>:<fpage>4486</fpage>&#8211;<lpage>4491</lpage>.<pub-id pub-id-type="pmid">18680227</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3748/wjg.14.4486</pub-id><pub-id pub-id-type="pmcid">PMC2731274</pub-id></mixed-citation></ref><ref id="R54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ewers</surname><given-names>M</given-names></name><name name-style="western"><surname>Canaff</surname><given-names>L</given-names></name><name name-style="western"><surname>Weh</surname><given-names>AE</given-names></name><etal/></person-group>. <article-title>The three common polymorphisms p.A986S, p.R990G and p.Q1011E in the calcium sensing receptor (CASR) are not associated with chronic pancreatitis</article-title>. <source>Pancreatology</source><year>2021</year>; <volume>21</volume>:<fpage>1299</fpage>&#8211;<lpage>1304</lpage>.<pub-id pub-id-type="pmid">34446336</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pan.2021.08.008</pub-id></mixed-citation></ref><ref id="R55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masamune</surname><given-names>A</given-names></name><name name-style="western"><surname>Kotani</surname><given-names>H</given-names></name><name name-style="western"><surname>Sorgel</surname><given-names>FL</given-names></name><etal/></person-group>. <article-title>Variants that affect function of calcium channel TRPV6 are associated with early-onset chronic pancreatitis</article-title>. <source>Gastroenterology</source><year>2020</year>; <volume>158</volume>:<fpage>1626</fpage>&#8211;<lpage>1641</lpage>.<pub-id pub-id-type="pmid">31930989</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2020.01.005</pub-id></mixed-citation></ref><ref id="R56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zou</surname><given-names>WB</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YC</given-names></name><name name-style="western"><surname>Ren</surname><given-names>XL</given-names></name><etal/></person-group>. <article-title>TRPV6 variants confer susceptibility to chronic pancreatitis in the Chinese population</article-title>. <source>Hum Mutat</source><year>2020</year>; <volume>41</volume>:<fpage>1351</fpage>&#8211;<lpage>1357</lpage>.<pub-id pub-id-type="pmid">32383311</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/humu.24032</pub-id></mixed-citation></ref><ref id="R57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oracz</surname><given-names>G</given-names></name><name name-style="western"><surname>Zarod</surname><given-names>M</given-names></name><name name-style="western"><surname>Ewers</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Loss of function TRPV6 variants are associated with chronic pancreatitis in nonalcoholic early-onset Polish and German patients</article-title>. <source>Pancreatology</source><year>2021</year>; <volume>21</volume>:<fpage>1434</fpage>&#8211;<lpage>1442</lpage>.<pub-id pub-id-type="pmid">34538581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pan.2021.09.005</pub-id></mixed-citation></ref><ref id="R58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olesen</surname><given-names>SS</given-names></name><name name-style="western"><surname>Harakow</surname><given-names>A</given-names></name><name name-style="western"><surname>Krogh</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Hypertriglyceridemia is often under recognized as an aetiologic risk factor for acute pancreatitis: a population-based cohort study</article-title>. <source>Pancreatology</source><year>2021</year>; <volume>21</volume>:<fpage>334</fpage>&#8211;<lpage>341</lpage>.<pub-id pub-id-type="pmid">33608229</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pan.2021.02.005</pub-id></mixed-citation></ref><ref id="R59"><label>59&#9642;</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>YY</given-names></name><name name-style="western"><surname>Li</surname><given-names>HX</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>WH</given-names></name></person-group>. <article-title>Hypertriglyceridemia-induced acute pancreatitis: progress on disease mechanisms and treatment modalities</article-title>. <source>Discov Med</source><year>2019</year>; <volume>27</volume>:<fpage>101</fpage>&#8211;<lpage>109</lpage>.<pub-id pub-id-type="pmid">30939294</pub-id></mixed-citation><note><p>A good overview of HTG-induced acute pancreatitis.</p></note></ref><ref id="R60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanchez</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Ge</surname><given-names>W</given-names></name><name name-style="western"><surname>Wei</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>The association of triglyceride levels with the incidence of initial and recurrent acute pancreatitis</article-title>. <source>Lipids Health Dis</source><year>2021</year>; <volume>20</volume>:<fpage>72</fpage>.<pub-id pub-id-type="pmid">34275452</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12944-021-01488-8</pub-id><pub-id pub-id-type="pmcid">PMC8286611</pub-id></mixed-citation></ref><ref id="R61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pedersen</surname><given-names>SB</given-names></name><name name-style="western"><surname>Langsted</surname><given-names>A</given-names></name><name name-style="western"><surname>Nordestgaard</surname><given-names>BG</given-names></name></person-group>. <article-title>Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis</article-title>. <source>JAMA Intern Med</source><year>2016</year>; <volume>176</volume>:<fpage>1834</fpage>&#8211;<lpage>1842</lpage>.<pub-id pub-id-type="pmid">27820614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2016.6875</pub-id></mixed-citation></ref><ref id="R62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berberich</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Hegele</surname><given-names>RA</given-names></name></person-group>. <article-title>A modern approach to dyslipidemia</article-title>. <source>Endocr Rev</source><year>2022</year>; <volume>43</volume>:<fpage>611</fpage>&#8211;<lpage>653</lpage>.<pub-id pub-id-type="pmid">34676866</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/endrev/bnab037</pub-id><pub-id pub-id-type="pmcid">PMC9277652</pub-id></mixed-citation></ref><ref id="R63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berberich</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Ouedraogo</surname><given-names>AM</given-names></name><name name-style="western"><surname>Shariff</surname><given-names>SZ</given-names></name><etal/></person-group>. <article-title>Incidence, predictors and patterns of care of patients with very severe hypertriglyceridemia in Ontario, Canada: a population-based cohort study</article-title>. <source>Lipids Health Dis</source><year>2021</year>; <volume>20</volume>:<fpage>98</fpage>.<pub-id pub-id-type="pmid">34479547</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12944-021-01517-6</pub-id><pub-id pub-id-type="pmcid">PMC8417954</pub-id></mixed-citation></ref><ref id="R64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sandhu</surname><given-names>S</given-names></name><name name-style="western"><surname>Al-Sarraf</surname><given-names>A</given-names></name><name name-style="western"><surname>Taraboanta</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study</article-title>. <source>Lipids Health Dis</source><year>2011</year>; <volume>10</volume>:<fpage>157</fpage>.<pub-id pub-id-type="pmid">21906399</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1476-511X-10-157</pub-id><pub-id pub-id-type="pmcid">PMC3180406</pub-id></mixed-citation></ref><ref id="R65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dron</surname><given-names>JS</given-names></name><name name-style="western"><surname>Hegele</surname><given-names>RA</given-names></name></person-group>. <article-title>Genetics of hypertriglyceridemia</article-title>. <source>Front Endocrinol (Lausanne)</source><year>2020</year>; <volume>11</volume>:<fpage>455</fpage>.<pub-id pub-id-type="pmid">32793115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2020.00455</pub-id><pub-id pub-id-type="pmcid">PMC7393009</pub-id></mixed-citation></ref><ref id="R66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paquette</surname><given-names>M</given-names></name><name name-style="western"><surname>Bernard</surname><given-names>S</given-names></name><name name-style="western"><surname>Hegele</surname><given-names>RA</given-names></name><name name-style="western"><surname>Baass</surname><given-names>A</given-names></name></person-group>. <article-title>Chylomicronemia: differences between familial chylomicronemia syndrome and multifactorial chylomicronemia</article-title>. <source>Atherosclerosis</source><year>2019</year>; <volume>283</volume>:<fpage>137</fpage>&#8211;<lpage>142</lpage>.<pub-id pub-id-type="pmid">30655019</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.atherosclerosis.2018.12.019</pub-id></mixed-citation></ref><ref id="R67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deshotels</surname><given-names>MR</given-names></name><name name-style="western"><surname>Hadley</surname><given-names>TD</given-names></name><name name-style="western"><surname>Roth</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Genetic testing for hypertriglyceridemia in academic lipid clinics: implications for precision medicine &#8211; brief report</article-title>. <source>Arterioscler Thromb Vasc Biol</source><year>2022</year>; <volume>42</volume>:<fpage>1461</fpage>&#8211;<lpage>1467</lpage>.<pub-id pub-id-type="pmid">36325899</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/ATVBAHA.122.318445</pub-id></mixed-citation></ref><ref id="R68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dron</surname><given-names>JS</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Cao</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Severe hypertriglyceridemia is primarily polygenic</article-title>. <source>J Clin Lipidol</source><year>2019</year>; <volume>13</volume>:<fpage>80</fpage>&#8211;<lpage>88</lpage>.<pub-id pub-id-type="pmid">30466821</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacl.2018.10.006</pub-id></mixed-citation></ref><ref id="R69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lazarte</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>McIntyre</surname><given-names>AD</given-names></name><name name-style="western"><surname>Hegele</surname><given-names>RA</given-names></name></person-group>. <article-title>Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2</article-title>. <source>J Clin Lipidol</source><year>2021</year>; <volume>15</volume>:<fpage>653</fpage>&#8211;<lpage>657</lpage>.<pub-id pub-id-type="pmid">34340952</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacl.2021.07.004</pub-id></mixed-citation></ref><ref id="R70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shamsudeen</surname><given-names>I</given-names></name><name name-style="western"><surname>Hegele</surname><given-names>RA</given-names></name></person-group>. <article-title>Safety and efficacy of therapies for chylomicronemia</article-title>. <source>Expert Rev Clin Pharmacol</source><year>2022</year>; <volume>15</volume>:<fpage>395</fpage>&#8211;<lpage>405</lpage>.<pub-id pub-id-type="pmid">35762447</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/17512433.2022.2094768</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>